comparemela.com
Home
Live Updates
LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year : comparemela.com
LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year
The novel agent has shown no immunogenicity issues thus far and might be a promising new PCSK9 inhibitor option.
Related Keywords
Baylor College Of Medicine
,
Texas
,
United States
,
Johannesburg
,
Gauteng
,
South Africa
,
Houston
,
Eric Klug
,
Christie Ballantyne
,
Md Baylor College Of Medicine
,
Pfizer
,
American College Of Cardiology
,
Mbbch University Of The Witwatersrand
,
Amgen
,
American College
,
Baylor College
,
comparemela.com © 2020. All Rights Reserved.